Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
1 study found for:    17962618 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Study of Vorinostat Plus Capecitabine (X) and Cisplatin (P) for 1st Line Treatment of Metastatic or Recurrent Gastric Cancer
Conditions: Gastric Cancer;   Histone Deacetylase Inhibitor
Intervention: Drug: Vorinostat, capecitabine, and cisplatin

Study has passed its completion date and status has not been verified in more than two years.